Zhejiang Puluo Pharmachem Co., Ltd. announces its subsidiary, Zhejiang Puluo Jiayuan Pharmaceutical Co., Ltd., has received a European Certificate of Suitability (CEP) for Gabapentin API from the EDQM. This signifies European regulatory approval, enabling market entry into the EU and other CEP-recognizing regions, positively impacting international market expansion.
Summary generated by AI · Always verify with source document
Stock Code: 000739 Stock Abbreviation: Puluo Pharmaceutical Announcement No.: 2026-64
Zhejiang Puluo Pharmachem Co., Ltd.
Announcement on Obtaining European CEP Certificate for Chemical API
The Company and the Board of Directors guarantee the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.